Boston Scientific wins approval for heart-device wire

NEW YORK, April 17 (Reuters) - Boston Scientific Corp. (BSX.N) said on Tuesday U.S. regulators approved a new wire for use with defibrillators and pacemakers to help deliver energy from the devices to the heart.

The approval comes a day after Boston Scientific said it resolved Food and Drug Administration concerns tied to its manufacturing plant for heart-rhythm devices, paving the way for the company to gain product approvals.

((Reporting by Lewis Krauskopf, editing by Maureen Bavdek; Reuters Messaging: Lewis.Krauskopf.reuters.com@reuters.net; lewis.krauskopf@reuters.com; 646-223-6082)) Keywords: BOSTONSCIENTIFIC/FDA

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWEN6524